Clinomics Inc. (KOSDAQ: 352770)

Clinomics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5,679	11,046	8,599	16,836	12,833	2,572
Short-Term Investments	950	2,101	9,196	22,147	17,101	14,740
Trading Asset Securities	-	-	-	4,961	-	-
Cash & Short-Term Investments	6,629	13,147	17,794	43,944	29,933	17,312
Cash Growth	-41.04%	-26.12%	-59.51%	46.81%	72.90%	457.31%
Accounts Receivable	1,224	1,106	29,580	27,097	1,586	1,132
Other Receivables	466.97	274.8	377.11	265.85	261.52	423.99
Receivables	5,312	1,839	30,622	28,091	1,856	1,582
Inventory	2,473	2,386	2,786	1,615	675.86	823.54
Prepaid Expenses	83.95	79.76	52.34	67.37	191.88	162.29
Other Current Assets	6,625	747.97	839.93	707.22	568.01	516.29
Total Current Assets	21,123	18,199	52,095	74,425	33,225	20,397
Property, Plant & Equipment	52,921	28,284	28,522	19,957	9,467	6,211
Long-Term Investments	13,306	11,268	13,921	6,934	97.04	-0
Goodwill	3,423	3,423	-	-	-	-
Other Intangible Assets	2,377	2,532	809.33	594.95	365.83	272.13
Long-Term Accounts Receivable	10,577	9,817	-	-	-	-
Other Long-Term Assets	1,408	448.47	1,276	676.98	605.17	56.28
Total Assets	105,698	74,484	97,104	102,587	43,760	26,936
Accounts Payable	791.01	509.9	53.66	73.79	214.62	69.32
Accrued Expenses	533.23	304.27	458.96	625.71	189.83	163.56
Short-Term Debt	26,825	9,316	13,379	13,297	-	-
Current Portion of Long-Term Debt	41.72	761.37	38.45	-	67.8	347.8
Current Portion of Leases	1,229	803.42	814.1	711.42	254.44	142.9
Current Income Taxes Payable	3,334	3,209	5,648	8,266	-	-
Other Current Liabilities	18,380	5,467	13,143	16,248	1,807	1,535
Total Current Liabilities	51,133	20,371	33,536	39,222	2,533	2,259
Long-Term Debt	5,942	7,689	3,888	145.87	203.4	18,615
Long-Term Leases	2,107	1,512	2,217	2,652	292.04	141.2
Long-Term Deferred Tax Liabilities	313.07	330.96	5.31	476.11	-	-
Other Long-Term Liabilities	651.58	627.11	403.21	297.76	123.38	97.6
Total Liabilities	61,132	31,576	40,762	43,974	3,841	21,886
Common Stock	3,889	3,198	1,362	1,347	1,332	907.09
Additional Paid-In Capital	101,481	90,122	64,902	62,369	60,771	15,076
Retained Earnings	-65,307	-58,005	-15,834	-7,318	-23,286	-10,432
Treasury Stock	-904.88	-904.88	-909	-909	-909	-909
Comprensive Income & Other	5,153	4,223	3,416	3,125	2,012	407.53
Total Common Equity	44,311	38,632	52,938	58,614	39,920	5,050
Minority Interest	255.2	364.59	258.59	-	-	-
Shareholders' Equity	44,566	42,908	56,342	58,614	39,920	5,050
Total Liabilities & Equity	105,698	74,484	97,104	102,587	43,760	26,936
Total Debt	36,145	20,082	20,337	16,807	817.68	19,247
Net Cash (Debt)	-29,516	-6,935	-2,543	27,138	29,115	-1,934
Net Cash Growth	-	-	-	-6.79%	-	-
Net Cash Per Share	-870.37	-257.83	-106.82	1264.88	1929.06	-151.68
Filing Date Shares Outstanding	38.88	31.97	19.96	19.73	19.5	13.61
Total Common Shares Outstanding	38.88	31.97	19.96	19.73	19.5	13.61
Working Capital	-30,010	-2,172	18,559	35,203	30,692	18,138
Book Value Per Share	1139.63	1208.35	2652.65	2970.54	2047.24	371.13
Tangible Book Value	38,511	32,677	52,129	58,019	39,554	4,778
Tangible Book Value Per Share	990.46	1022.09	2612.10	2940.39	2028.48	351.13
Land	33,997	12,232	10,147	5,494	960.57	988.07
Buildings	13,936	11,669	10,293	3,454	2,305	2,325
Machinery	17,184	16,437	11,106	9,775	6,931	3,424
Construction In Progress	631.12	-	427.53	1,640	400	68

Source: S&P Capital IQ. Standard template. Financial Sources.